TY - JOUR
T1 - NKX2-5 mutations causative for congenital heart disease retain functionality and are directed to hundreds of targets
AU - Bouveret, Romaric
AU - Waardenberg, Ashley J.
AU - Schonrock, Nicole
AU - Ramialison, Mirana
AU - Doan, Tram
AU - de jong, Danielle
AU - Bondue, Antoine
AU - Kaur, Gurpreet
AU - Mohamed, Stephanie
AU - Fonoudi, Hananeh
AU - Chen, Chiann Mun
AU - Wouters, Merridee A.
AU - Bhattacharya, Shoumo
AU - Plachta, Nicolas
AU - Dunwoodie, Sally L.
AU - Chapman, Gavin
AU - Blanpain, Cédric
AU - Harvey, Richard P.
N1 - Publisher Copyright:
© 2015, Bouveret et al.
PY - 2015/7/6
Y1 - 2015/7/6
N2 - We take a functional genomics approach to congenital heart disease mechanism. We used DamID to establish a robust set of target genes for NKX2-5 wild type and disease associated NKX2-5 mutations to model loss-of-function in gene regulatory networks. NKX2-5 mutants, including those with a crippled homeodomain, bound hundreds of targets including NKX2-5 wild type targets and a unique set of "off-targets", and retained partial functionality. NKXΔHD, which lacks the homeodomain completely, could heterodimerize with NKX2-5 wild type and its cofactors, including E26 transformationspecific (ETS) family members, through a tyrosine-rich homophilic interaction domain (YRD). Off-targets of NKX2-5 mutants, but not those of an NKX2-5 YRD mutant, showed overrepresentation of ETS binding sites and were occupied by ETS proteins, as determined by DamID. Analysis of kernel transcription factor and ETS targets show that ETS proteins are highly embedded within the cardiac gene regulatory network. Our study reveals binding and activities of NKX2-5 mutations on WT target and off-targets, guided by interactions with their normal cardiac and general cofactors, and suggest a novel type of gainof- function in congenital heart disease.
AB - We take a functional genomics approach to congenital heart disease mechanism. We used DamID to establish a robust set of target genes for NKX2-5 wild type and disease associated NKX2-5 mutations to model loss-of-function in gene regulatory networks. NKX2-5 mutants, including those with a crippled homeodomain, bound hundreds of targets including NKX2-5 wild type targets and a unique set of "off-targets", and retained partial functionality. NKXΔHD, which lacks the homeodomain completely, could heterodimerize with NKX2-5 wild type and its cofactors, including E26 transformationspecific (ETS) family members, through a tyrosine-rich homophilic interaction domain (YRD). Off-targets of NKX2-5 mutants, but not those of an NKX2-5 YRD mutant, showed overrepresentation of ETS binding sites and were occupied by ETS proteins, as determined by DamID. Analysis of kernel transcription factor and ETS targets show that ETS proteins are highly embedded within the cardiac gene regulatory network. Our study reveals binding and activities of NKX2-5 mutations on WT target and off-targets, guided by interactions with their normal cardiac and general cofactors, and suggest a novel type of gainof- function in congenital heart disease.
UR - http://www.scopus.com/inward/record.url?scp=84940567692&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84940567692&partnerID=8YFLogxK
U2 - 10.7554/eLife.06942
DO - 10.7554/eLife.06942
M3 - Article
C2 - 26146939
AN - SCOPUS:84940567692
SN - 2050-084X
VL - 4
JO - eLife
JF - eLife
IS - JULY2015
M1 - e06942
ER -